Internal Medicine III, Wakayama Medical University, 811-1 Kimiidera, Wakayama-shi, Wakayama, 641-8509, Japan.
Center for Biomedical Sciences, Wakayama Medical University, 811-1 Kimiidera, Wakayama-shi, Wakayama, 641-8509, Japan.
BMC Cancer. 2022 Nov 8;22(1):1148. doi: 10.1186/s12885-022-10246-7.
KRAS-mutated non-small cell lung cancer (NSCLC) accounts for 23-35% and 13-20% of all NSCLCs in white patients and East Asians, respectively, and is therefore regarded as a major therapeutic target. However, its epidemiology and clinical characteristics have not been fully elucidated because of its wide variety of mutational subtypes. Here, we focused on two distinct base substitution types: transversion mutations and transition mutations, as well as their association with environmental factors and clinical outcome.
Dataset from the Japan Molecular Epidemiology Study, which is a prospective, multicenter, and molecular study epidemiology cohort study involving 957 NSCLC patients who underwent surgery, was used for this study. Questionnaire-based detailed information on clinical background and lifestyles was also used to assess their association with mutational subtypes. Somatic mutations in 72 cancer-related genes were analyzed by next-generation sequencing, and KRAS mutations were classified into three categories: transversions (G > C or G > T; G12A, G12C, G12R, G12V), transitions (G > A; G12D, G12S, G13D), and wild-type (WT). Clinical correlations between these subtypes have been investigated, and recurrence-free survival (RFS) and overall survival (OS) were evaluated.
Of the 957 patients, KRAS mutations were detected in 80 (8.4%). Of these, 61 were transversions and 19 were transitions mutations. Both pack-years of smoking and smoking duration had significant positive correlation with the occurrence of transversion mutations (p = 0.03 and < 0.01, respectively). Notably, transitions showed an inverse correlation with vegetable intake (p = 0.01). Patients with KRAS transitions had the shortest RFS and OS compared to KRAS transversions and WT. Multivariate analysis revealed that KRAS transitions, along with age and stage, were significant predictors of shorter RFS and OS (HR 2.15, p = 0.01; and HR 2.84, p < 0.01, respectively).
Smoking exposure positively correlated with transversions occurrence in a dose-dependent manner. However, vegetable intake negatively correlated with transitions. Overall, KRAS transition mutations are significantly poor prognostic factors among resected NSCLC patients.
KRAS 突变型非小细胞肺癌(NSCLC)在白人患者和东亚人中分别占所有 NSCLC 的 23-35%和 13-20%,因此被视为主要的治疗靶点。然而,由于其突变亚型种类繁多,其流行病学和临床特征尚未完全阐明。在这里,我们重点关注两种不同的碱基替换类型:颠换突变和转换突变,以及它们与环境因素和临床结果的关系。
本研究使用了来自日本分子流行病学研究(Japan Molecular Epidemiology Study)的数据,这是一项涉及 957 例接受手术的 NSCLC 患者的前瞻性、多中心、分子研究流行病学队列研究。还使用基于问卷的详细临床背景和生活方式信息来评估它们与突变亚型的关系。通过下一代测序分析 72 个癌症相关基因的体细胞突变,将 KRAS 突变分为三类:颠换(G>C 或 G>T;G12A、G12C、G12R、G12V)、转换(G>A;G12D、G12S、G13D)和野生型(WT)。研究了这些亚型之间的临床相关性,并评估了无复发生存率(RFS)和总生存率(OS)。
在 957 例患者中,检测到 80 例(8.4%)存在 KRAS 突变。其中 61 例为颠换突变,19 例为转换突变。吸烟包年数和吸烟持续时间与颠换突变的发生呈显著正相关(p=0.03 和 p<0.01)。值得注意的是,蔬菜摄入量与转换突变呈负相关(p=0.01)。与 KRAS 颠换和 WT 相比,KRAS 转换患者的 RFS 和 OS 最短。多变量分析显示,KRAS 转换以及年龄和分期是 RFS 和 OS 较短的显著预测因素(HR 2.15,p=0.01;和 HR 2.84,p<0.01)。
吸烟暴露与颠换突变的发生呈剂量依赖性正相关。然而,蔬菜摄入量与转换突变呈负相关。总体而言,KRAS 转换突变是 NSCLC 患者术后明显的不良预后因素。